Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/586082
Full metadata record
DC FieldValueLanguage
dc.coverage.spatialAntituberculosis Medications
dc.date.accessioned2024-08-29T06:25:17Z-
dc.date.available2024-08-29T06:25:17Z-
dc.identifier.urihttp://hdl.handle.net/10603/586082-
dc.description.abstractTuberculosis poses a significant worldwide health problem for children, and the occurrence of multi-drug-resistant (MDR) tuberculosis in children is on the alarming rise. Traditional adult oral immediate release tablets are often impractical for kids, leaving a scarcity of child-friendly formulations. This research seeks to mitigate the potential hazards of blocking associated with the orally taken conventional dosage forms, thereby enhancing safety, administration convenience, bioavailability, and achieving a rapid onset of action. In this study, three dosage forms were formulated which include, granules, chewable tablets, and dispersible tablets of Moxifloxacin. The research study includes different steps which include preformulation as an initial step. Preformulation was done to determine the compatibility between API and excipients. Every parameter checked for preformulation were found within limit and hence no incompatibility was observed in the Moxifloxacin and other excipients used the formulation. newlineUsing the wet granulation method, granules were created by combining taste-masking agents with excipients like mannitol 160 C, aspartame as taste masking agent, and Lemon flavor as a flavoring agent. Flow properties of the granules were checked and found within limit for formulation F6. For optimized formulation, a variety of dissolution media, including 0.1 N HCl, phosphate buffer at pH 6.8 and 7.4, and acetate buffer at pH 4.5, were used for the in vitro dissolution investigation. It was found 100 % release at 12 min in 0.1N HCl. Also, other analysis were done like FTIR, DSC, XRD for which results collectively demonstrated that Moxifloxacin existed in a crystalline form in optimized formulation. In taste masking evaluation desirable results were achieved. In chewable tablets also, direct compression method was utilised and all the physicochemical parameters for tablets were determined which were found satisfactory. Several dissolve media, such as 0.1 N HCl, phosphate buffer pH 6.8 and pH 7.4, and acetate buffe
dc.format.extent181p
dc.languageEnglish
dc.relation134b
dc.rightsuniversity
dc.titleDesign and Development of Pediatric Formulations of Second line Antituberculosis Medications
dc.title.alternative
dc.creator.researcherNevle, Shyamkant S.
dc.subject.keywordClinical Pre Clinical and Health
dc.subject.keywordPharmacology and Pharmacy
dc.subject.keywordPharmacology and Toxicology
dc.description.note
dc.contributor.guideButle, Santosh R.
dc.publisher.placeNanded
dc.publisher.universitySwami Ramanand Teerth Marathwada University
dc.publisher.institutionDepartment of Pharmacy
dc.date.registered2015
dc.date.completed2024
dc.date.awarded2024
dc.format.dimensions
dc.format.accompanyingmaterialNone
dc.source.universityUniversity
dc.type.degreePh.D.
Appears in Departments:Department of Pharmacy

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File52.18 kBAdobe PDFView/Open
02_prelim_pages.pdf419.5 kBAdobe PDFView/Open
03_contents.pdf155.47 kBAdobe PDFView/Open
04_abstract.pdf86.62 kBAdobe PDFView/Open
05_chapter_1.pdf348.53 kBAdobe PDFView/Open
06_chapter_2.pdf99.12 kBAdobe PDFView/Open
07_chapter_3.pdf33.97 kBAdobe PDFView/Open
08_chapter_4.pdf100.8 kBAdobe PDFView/Open
09_chapter_5.pdf259.05 kBAdobe PDFView/Open
10_chapter_6.pdf1.7 MBAdobe PDFView/Open
11_chapter_7.pdf157.31 kBAdobe PDFView/Open
12_chapter_9.pdf34.02 kBAdobe PDFView/Open
13_annexures.pdf1.11 MBAdobe PDFView/Open
80_recommendation.pdf199.09 kBAdobe PDFView/Open


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: